Telix Pharmaceuticals Limited Share Price
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
06:10:10 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 15.73 AUD | +4.31% |
|
-0.76% | +40.45% |
| 09-11 | ASX Biggest Losers | MT |
| 09-03 | ASX Biggest Gainers | MT |
| Market Cap | 5.34B 3.72B 3.31B 3.06B 2.79B 5.26B 353B 36.83B 14.44B 184B 13.96B 13.66B 587B | P/E 2026 * |
221x | P/E 2027 * | 957x |
|---|---|---|---|---|---|
| Enterprise Value | 5.86B 4.08B 3.62B 3.36B 3.06B 5.77B 387B 40.38B 15.83B 202B 15.3B 14.98B 644B | EV / Sales 2026 * |
4.22x | EV / Sales 2027 * | 3.68x |
| Free-Float |
84.32% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| TLX | Delayed | |
Deutsche Boerse AG
| T3X | Delayed | |
|
OTC Markets
| TLPPF | Delayed | |
|
Tradegate
| T3X | Real-time | |
|
Boerse Muenchen
| T3X | Real-time | |
|
Börse Stuttgart
| T3X | Delayed |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | +4.31% | ||
| 1 week | -0.76% | ||
| Current month | +0.06% | ||
| 1 month | -6.76% | ||
| 3 months | +0.77% | ||
| 6 months | +4.87% | ||
| Current year | +40.45% |
| 1 week | 14.75 |  | 16.5 |
| 1 month | 14.75 | | 18.11 |
| Current year | 8.26 | | 18.22 |
| 1 year | 8.26 | | 18.22 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 02/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 30/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 02/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 02/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 18/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/09/26 | Buy | Chairman | 11,800 | 0.0035% | ||
| 07/09/26 | Buy | Chief Financial Officer | 2,071 | 0.0006% | ||
| 26/05/26 | Free | Director | 21,597 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.31% | -0.76% | -7.14% | +51.10% | 3.55B | |
| -6.60% | -10.93% | +45.08% | +60.01% | 68.98B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 53.15B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 50.83B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 44.61B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 40.57B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 42.53B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 30.95B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.44B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.66B | |
| Average | -1.23% | -0.83% | +38.51% | +81.83% | 38.33B | |
| Weighted average by Cap. | -2.37% | -0.14% | +44.67% | +89.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.39B 967M 860M 797M 725M 1.37B 91.78B 9.58B 3.76B 47.9B 3.63B 3.55B 153B | 1.58B 1.1B 978M 906M 825M 1.56B 104B 10.89B 4.27B 54.48B 4.13B 4.04B 174B |
| Net income | 27.44M 19.09M 16.97M 15.73M 14.31M 27.01M 1.81B 189M 74.14M 946M 71.66M 70.13M 3.01B | 6.17M 4.29M 3.81M 3.54M 3.22M 6.07M 407M 42.5M 16.66M 213M 16.11M 15.76M 678M |
| Net Debt | 515M 358M 319M 295M 269M 507M 34.01B 3.55B 1.39B 17.75B 1.34B 1.32B 56.57B | 475M 331M 294M 272M 248M 468M 31.38B 3.27B 1.28B 16.38B 1.24B 1.21B 52.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | A$15.73 | +4.31% | 1,369,067 |
| 15/10/26 | A$15.08 | -1.69% | 1,815,274 |
| 14/10/26 | A$15.34 | -2.79% | 1,105,381 |
| 13/10/26 | A$15.78 | -3.19% | 1,348,264 |
| 12/10/26 | A$16.30 | +2.84% | 1,213,896 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
